Fluorescent biosensors for probing CDK4/cyclin D activity and developing non-ATP pocket Inhibitors for melanoma, lung cancer and lymphoma

被引：0
|
作者：
Morris, May [1 ]
Prevel, Camille [1 ]
Pellerano, Morgan [1 ]
Thi Nhu Ngoc Van [1 ]
机构：
[1] IBMM CNRS 5247, Montpellier, France
来源：
FASEB JOURNAL | 2014年 / 28卷 / 01期
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
972.2
引用
收藏
页数：2
相关论文
共 31 条
  • [21] Anticancer activity of britannin through the downregulation of cyclin D1 and CDK4 in human breast cancer cells (vol 15, pg 1105, 2019)
    Hamzeloo-Moghadam, M.
    Aghaei, M.
    Abdolmohammadi, Mohammad Hossein
    Fallahian, F.
    JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2019, 15 (06) : 1424 - 1424
  • [22] Iron deprivation inhibits cyclin-dependent kinase activity and decreases cyclin D CDK4 protein levels in asynchronous MDA-MB-453 human breast cancer cells
    Kulp, KS
    Green, SL
    Vulliet, PR
    EXPERIMENTAL CELL RESEARCH, 1996, 229 (01) : 60 - 68
  • [23] Iron deprivation inhibits cyclin-dependent kinase activity and decreases cyclin D/CDK4 protein levels in asynchronous MDA-MB-453 human breast cancer cells.
    Kulp, KS
    Green, SL
    Vulliet, PR
    MOLECULAR BIOLOGY OF THE CELL, 1996, 7 : 2135 - 2135
  • [24] Clinical activity of LY2835219, a novel cell cycle inhibitor selective for CDK4 and CDK6, in patients with non-small cell lung cancer.
    Goldman, Jonathan Wade
    Gandhi, Leena
    Patnaik, Amita
    Rosen, Lee S.
    Hilton, John Frederick
    Papadopoulos, Kyriakos P.
    Tolaney, Sara M.
    Beeram, Muralidhar
    Rasco, Drew Warren
    Myrand, Scott P.
    Beckmann, Richard P.
    Kulanthaivel, Palaniappan
    Frenzel, Martin
    Cronier, Damien
    Chan, Edward M.
    Flaherty, Keith
    Wen, Patrick Y.
    Tolcher, Anthony W.
    Shapiro, Geoffrey
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [25] Preclinical Activity of Simvastatin Induces Cell Cycle Arrest in G1 via Blockade of Cyclin D-Cdk4 Expression in Non-Small Cell Lung Cancer (NSCLC)
    Liang, Yu-Wei
    Chang, Chi-Chang
    Hung, Chao-Ming
    Chen, Tzu-Yu
    Huang, Tzuu-Yuan
    Hsu, Yi-Chiang
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2013, 14 (03): : 5806 - 5816
  • [26] CDK4/6 signaling attenuates the effect of epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors in EGFR-mutant non-small cell lung cancer
    Hara, Naofumi
    Ichihara, Eiki
    Kano, Hirohisa
    Ando, Chihiro
    Morita, Ayako
    Nishi, Tatsuya
    Okawa, Sachi
    Nakasuka, Takamasa
    Hirabae, Atsuko
    Abe, Masaya
    Asada, Noboru
    Ninomiya, Kiichiro
    Makimoto, Go
    Fujii, Masanori
    Kubo, Toshio
    Ohashi, Kadoaki
    Hotta, Katsuyuki
    Tabata, Masahiro
    Maeda, Yoshinobu
    Kiura, Katsuyuki
    TRANSLATIONAL LUNG CANCER RESEARCH, 2023, 12 (10) : 2098 - +
  • [27] Cell cycle regulators cyclin D1 and CDK4/6 have estrogen receptor-dependent divergent functions in breast cancer migration and stem cell-like activity
    Lamb, Rebecca
    Lehn, Sophie
    Rogerson, Lynsey
    Clarke, Robert B.
    Landberg, Goran
    CELL CYCLE, 2013, 12 (15) : 2384 - 2394
  • [28] Druggable CRISPR/Cas9 screen identifies Cyclin E1 (CCNE1) as a key mediator of sensitivity to CDK4/6 inhibition in non-small cell lung cancer (NSCLC)
    Bott, Matthew
    Skamagki, Maria
    Salgado, Nelson
    Sanchez-Rivera, Francisco
    Lowe, Scott
    CANCER RESEARCH, 2023, 83 (07)
  • [29] Licorice extract inhibits growth of non-small cell lung cancer by down-regulating CDK4-Cyclin D1 complex and increasing CD8+ T cell infiltration
    Jinglin Zhu
    Ruifei Huang
    Ruijie Yang
    Yue Xiao
    Jiangna Yan
    Chunli Zheng
    Wei Xiao
    Chao Huang
    Yonghua Wang
    Cancer Cell International, 21
  • [30] Licorice extract inhibits growth of non-small cell lung cancer by down-regulating CDK4-Cyclin D1 complex and increasing CD8+ T cell infiltration
    Zhu, Jinglin
    Huang, Ruifei
    Yang, Ruijie
    Xiao, Yue
    Yan, Jiangna
    Zheng, Chunli
    Xiao, Wei
    Huang, Chao
    Wang, Yonghua
    CANCER CELL INTERNATIONAL, 2021, 21 (01)
1234